Cite Filings / CHRS
Feed Companies Filings Check
Sign in

CIK 0001512762 · Accelerated filer<br>Smaller reporting company

Coherus Oncology, Inc.

Sign in to watch
Ticker
CHRS
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
273615821
Phone
(650) 649-3530
Business address
C/O DENNIS M. LANFEAR, 333 TWIN DOLPHIN DR, SUITE 600, REDWOOD CITY, CA, 94065
Former names
Coherus BioSciences, Inc., BioGenerics, Inc.
Filings Insiders Search text
All 923 Financials 253 Shareholder Meetings 13 Executive Compensation 227 Insider Trading 399 Beneficial Ownership Interest 103 Business Combinations 217 Public Offerings 65 Mutual Funds and ETFs 12 Others 88
›
Filed in
  1. No filings match these filters. Clear filters
  2. DEF 14A Proxy Proxy Statement 2026-04-20
  3. PRE 14A Proxy Proxy Statement (Preliminary) 2026-04-09
  4. DEF 14A Proxy Proxy Statement 2025-04-29
  5. DEF 14A Proxy Proxy Statement 2024-04-15
  6. DEF 14A Proxy Proxy Statement 2023-04-17
  7. DEF 14A Proxy Proxy Statement 2022-04-04
  8. DEF 14A Proxy Proxy Statement 2021-04-09
  9. DEF 14A Proxy Proxy Statement 2020-04-06
  10. DEF 14A Proxy Proxy Statement 2019-04-10
  11. DEF 14A Proxy Proxy Statement 2018-04-13
  12. DEF 14A Proxy Proxy Statement 2017-04-06
  13. DEF 14A Proxy Proxy Statement 2016-04-08
  14. DEF 14A Proxy Proxy Statement 2015-04-09

Page 1 of 1 · 13 filings

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…